S'abonner

Impact of novel Accurate Mass MS/MSALL acquisition and processing techniques on forensic toxicological screening - 07/05/15

Doi : 10.1016/j.toxac.2015.03.079 
D.M. Cox 1, M. Jarvis 1, E. Mcclure 1, A.M. Taylor 1, A. Morla 2,
1 Sciex, Concord, Ontario, Canada 
2 Sciex, Les Ulis, France 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 2
Iconographies 0
Vidéos 0
Autres 0

Résumé

Aim

Rapid forensic toxicology screening by high-resolution mass spectrometry is a powerful technique. However, some compounds cannot be unambiguously identified with high-resolution MS1 measurements alone. MS/MS fragmentation yields confident identifications of these compounds, but how to ensure quality in MS/MS of these compounds? Data dependent techniques, although very powerful, cannot guarantee the measurement of all possible MS/MS candidates. Targeted MS/MS ensures acquisition of the target compounds, but limits the number of compounds. Data-independent techniques, such as SWATH™ acquisition (the MS/MS of all possible candidates), improve identifications significantly and enable retrospective analysis of the data.

Objectives

To evaluate the impact of improvements to SWATH acquisition, including variable precursor window sizes, overlapping windows and deconvolution of MS/MS from multiple precursors.

Methods

Urine was spiked with over 120 drugs and compounds often found in forensics screening panels. The data was collected on a Triple TOF® 5600 system using one of the following methods:

– using a ToF-MS survey scan with IDA-triggering (Information Dependant Acquisition) of up to 20 product ion scans;

– SWATH acquisition.

For SWATH acquisition, the precursor isolation window width was variable for each MS/MS experiment, or the windows were overlapped between each cycle.

Data was processed in PeakView® software 2.0, using a research prototype of MasterView™ software.

Results

Astemizole and Amlodipine both demonstrated the advantage of having narrower SWATH isolation windows. The overlap 20Da SWATH window acquisition (after demultiplexing was performed) resulted in MS/MS that were significantly reduced in interferences. The library match purity scores were improved from 2.2% to 97.5% and 38.8% to 92.7%, respectively. Having narrower isolation windows improves the specificity of MS/MS data, but at a cost. Either accumulation times must be decreased (which would make signal to noise worse) or cycle times will get longer (reducing the number of points across a peak). We show with the example of Berberine that using overlap SWATH acquisition that the demultiplexed MS/MS can approach the quality of a true 10Da SWATH acquisition MS/MS, while having an improved cycle time. Deconvolution of SWATH MS/MS was also shown to improve library match purity scores. Unprocessed SWATH MS/MS had significantly lower purity scores for many compounds. Simple background subtraction resulted in MS/MS of much better quality. Two other deconvolution techniques were tried. Method A was similar to techniques used for deconvolving GC-MS signals, and was implemented to run on an NVIDIA 660 graphics card. Method B is novel technique making use of principal components variable grouping (PCVG) to obtain a SWATH MS/MS. When the techniques were combined, results were equivalent to those achieved using unit resolution IDA. For a few compounds, IDA was not triggered, resulting in no identification. While the SWATH acquisition was able to confidently identify these compounds with good purity scores.

Conclusion

SWATH acquisition methods acquire MS/MS for all compounds, at every time point, achieve identification results comparable to unit resolution IDA methods and overlap SWATH acquisition can improve cycle times and improve identification results.

Le texte complet de cet article est disponible en PDF.

Plan


© 2015  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 27 - N° 2S

P. S52-S53 - juin 2015 Retour au numéro
Article précédent Article précédent
  • Épidémiologie et suivi des appels reçus au CPVL et au CNITV concernant les cas d’exposition humaine à des médicaments vétérinaires entre 2004 et 2014
  • E. Adamczyk, L. Tavernier, F. Roque, S. Queffelec, X. Pineau
| Article suivant Article suivant
  • High-sensitivity analysis of THC-COOH and THC in oral fluid
  • X. He, A. Wang, A.M. Taylor, A. Morla

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.